Navigation Links
Polymedco Aligns with MedPrimex to Fight Colorectal Cancer in Mexico
Date:8/30/2012

CORTLANDT MANOR, N.Y., Aug. 30, 2012 /PRNewswire/ -- Polymedco Cancer Diagnostic Products, LLC ("Polymedco CDP") is pleased to announce that a distribution agreement was signed with MedPrimex, LLC ("MedPrimex").  The agreement provides distribution rights, for the Mexican market, to MedPrimex for Polymedco CDP fecal immunochemical test (FIT) product line for screening for colorectal cancer (CRC).  Colorectal cancer is among the leading causes of cancer death worldwide, but nearly half of people who die failed to get screened.

Early detection and treatment dramatically increase chances of survival. Screening is the most realistic approach to reducing new cases by finding non-cancerous colorectal polyps and removing them before they become cancerous. 

The OC automated FIT and manual OC Light® tests are quick and easy screening methods that measure human hemoglobin in the patient's stool.  The tests can be performed at home with little disruption to the patient's daily routine – requiring only one sample collection and no changes to diet or medication. The higher specificity of FIT means that there are less false positive results.

"Our goal is to introduce the benefits of getting an annual screening using a fecal immunochemical test (FIT) to people of Mexico," said Drew Cervasio, President of Polymedco. "Innovations in screening have significantly improved the detection of breast, prostate and cervical cancers so it is time to pay attention to the advances that can drive more patients to find colorectal cancer earlier."

"Through these screening tests, we are better able to accurately identify at-risk patients and send more of the right patients for further evaluation and colonoscopy," said Ana Maria Pedroza, CEO of MedPrimex. "We are proud to be a part of an effort that will ensure citizens of our country will have access to the best options for their healthcare needs."

About Polymedco Cancer Diagnostic Products, LLC

Polymedco Cancer Diagnostic Products, LLC is a leading manufacturer, marketer, and distributer in the clinical laboratory marketplace. Polymedco supplies clinical diagnostic test kits and devices that are specialized in cancer. We are a world leader in non-invasive colorectal cancer screening technology, providing the new standard of care with the OC -Auto® product line. Since 1980, Polymedco has evolved into a highly skilled and successful marketing, sales, and manufacturing organization.

Combined with an experienced team of field representatives and strong technical service personnel, Polymedco Cancer Diagnostic Products provides a high level of customer, technical and reimbursement support. To reach Polymedco Inc. via the worldwide web, log on to www.polymedco.com.

About MedPrimex, LLC

MedPrimex is a trusted Mexican company specialized in providing medical equipment, early detection systems, and disease prevention to preserve the health of the Mexican population. MedPrimex has strong ties with lead companies to deliver innovative health system solutions and advance medical technology. MedPrimex goal is preserving the health and quality of life of people.

MedPrimex has unparalleled service, expertise, product, and service offerings — delivering solutions that are innovative and practical. MedPrimex focuses on what matters most - improving people's lives. MedPrimex strives to work for the success of their customers by providing exceptional value and superior service to best satisfy their needs.

To reach MedPrimex via the worldwide web, log on to www.medprimex.com.


'/>"/>
SOURCE Polymedco Cancer Diagnostic Products, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmacists United for Truth and Transparency Marks One Year Anniversary of Fighting Abuses by Pharmacy Benefits Managers
2. Back to School Ideas: Vaccines for Kids Could Hurt Rather Than Help Fight Disease
3. Global pharmaceutical industry calls for broad-based cooperation to fight online sales of counterfeit medicines around the world
4. Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On Market After Removal Due To Environmental Treaty
5. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
6. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
7. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
8. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
9. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
10. Breast Cancer Diagnostic and Drug Technologies: Global Markets
11. Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The American Cleft ... ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the event. , ... exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):